High fluoroquinolone MIC is associated with fluoroquinolone treatment failure in urinary tract infections caused by fluoroquinolone susceptible Escherichia coli

BACKGROUND: Suboptimal clinical response to fluoroquinolone (FQ) therapy has been clearly documented in patients with Salmonella typhi infection with reduced FQ susceptibility. However, the clinical impact of reduced FQ susceptibility on other infections including E. coli urinary tract infections (U...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Ann Clin Microbiol Antimicrob
Huvudupphovsmän: Rattanaumpawan, Pinyo, Nachamkin, Irving, Bilker, Warren B., Roy, Jason A., Metlay, Joshua P., Zaoutis, Theoklis E., Lautenbach, Ebbing
Materialtyp: Artigo
Språk:Inglês
Publicerad: BioMed Central 2017
Ämnen:
Short Report
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5385084/
https://ncbi.nlm.nih.gov/pubmed/28390438
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12941-017-0202-4
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk